ALVO · NASDAQ · Drug Manufacturers - Specialty & Generic

Alvotech

Develops and manufactures biosimilar medicines through an integrated platform and partner network.

$4.94
After-hours close+0.01 (+0.10%)
At close$4.94(+1.13%)

Breakdown13F · Form 4

Institutions 5.03%Insiders

Shares outstanding 338.22M · Float 103.22M · 30.5% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
Celtic Holdings S.C.A.107.45M27.50%13DJun 30, 2026
Aztiq Pharma Partners S.a r.l.103.85M33.30%13DMar 12, 2026
Vanguard Capital Management LLC3.41M1.01%13FMay 15, 2026
Bracebridge Capital, LLC2.71M0.80%13FMay 15, 2026
Millennium Management LLC2.12M0.63%13FMay 15, 2026

Institutions13F, as of Mar 31, 2026

57 holders · 17.00M shares · 16 new positions · 40 increased · 10 reduced · 9 closed

HolderShares% outstandingChg q/qFiled
Vanguard Capital Management LLC3.41M1.01%+3.41MnewMay 15, 2026
Bracebridge Capital, LLC2.71M0.80%0May 15, 2026
Millennium Management LLC2.12M0.63%+1.77MMay 15, 2026
Price T Rowe Associates Inc /MD/1.40M0.41%−37.0KMay 15, 2026
Littlejohn & Co LLC1.32M0.39%0May 14, 2026
BlackRock, Inc.1.25M0.37%+69.2KMay 13, 2026
Vanguard Fiduciary Trust Co974.2K0.29%+974.2KnewMay 8, 2026
Legal & General Group PLC504.5K0.15%−77.1KMay 8, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Aztiq Pharma Partners S.a r.l.incl. ATP Holdings ehf., Aztiq Fund I SCSp +2 more33.30%103.85M13DMar 12, 2026
Celtic Holdings S.C.A.incl. Celtic Lux Holdings S.a r.l.27.50%107.45M13DJun 30, 2026

InsidersForm 4

Latest trades

Nothing filed in the last 12 months.

CongressHouse and Senate disclosures

Not reported.